Enanta Pharmaceuticals Inc (ENTA)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
346,010,000
EV to revenue ratio (TTM)
3.282
EV to ebitda
41.13
Financial Performance
Revenue (TTM)
65,258,000
Gross profit (TTM)
65,258,000
EBITDA
-53,819,000
Profitability
Operating margin (TTM)
-120.00%
Profit margin
-96.90%
Return on assets (TTM)
-12.30%
Return on equity (TTM)
-70.10%
Per Share Metrics
Revenue per share (TTM)
2.41
EPS
-2.42
Diluted EPS (TTM)
-2.42
Book value
3.47
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
44.05
PEG ratio
0
Price to sales ratio (TTM)
5.3
Price to book ratio (TTM)
3.444
Growth
Quarterly earnings growth (YoY)
-21.60%
Quarterly revenue growth (YoY)
-66.20%
Analyst Sentiment
Strong buy
1
Buy
5
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.938